Vivitrol

Warnings and Precautions for Vivitrol

Vivitrol does not carry a formal FDA boxed warning. However, patients and prescribers should be aware of the following important safety information.

Risk of Opioid Overdose

Patients who have been treated with Vivitrol have reduced tolerance to opioids. If a patient relapses and uses opioids after their tolerance has decreased, there is a risk of fatal overdose, including at doses previously tolerated.

Precipitated Opioid Withdrawal

Patients must be opioid-free for a minimum of 7 to 10 days before starting Vivitrol, as starting treatment too soon after opioid use can precipitate severe withdrawal symptoms.

Injection Site Reactions

Severe injection site reactions, in some cases requiring surgical intervention, have been reported. Injection sites should be monitored for signs of significant or worsening reactions.

Hepatotoxicity

Cases of hepatitis and liver dysfunction have been reported. Liver function should be monitored, particularly in patients with pre-existing liver conditions.

How to Access Vivitrol in India: A 6-Step Process

Step 1 – Search & request your medicine: The patient or treating doctor submits a request with basic details to initiate the access process.

Step 2 – Verification & eligibility review: The team verifies availability and reviews eligibility against regulatory and clinical requirements to ensure a compliant pathway.

Step 3 – Receive quote & delivery timeline: A transparent quotation is shared, covering medicine cost, logistics, and a clear delivery timeline.

Step 4 – Regulatory approval process: Assistance is provided to secure the approvals and documentation required for legal cross-border access.

Step 5 – Temperature-controlled import & handling: The medicine is sourced and transported under strict GDP-compliant conditions to maintain product integrity.

Step 6 – Secure delivery: The medicine is delivered to the patient or treating hospital, with updates provided at each stage.

Note: From request to delivery, every step is designed to ensure your treatment reaches you safely, compliantly, and without unnecessary delays.

Documentation and Availability of Vivitrol

Vivitrol is manufactured and marketed by Alkermes, Inc. It is sourced through authorized distribution channels for patients seeking named-patient import into India.

Required Documentation

Patients typically need a valid prescription from a treating addiction medicine specialist confirming diagnosis and, for opioid use disorder, confirmation of completed detoxification. NPP's regulatory team assists in preparing and verifying the documentation needed for a compliant import.

Availability

As an FDA-approved therapy for alcohol dependence and opioid relapse prevention, Vivitrol is sourced through authorized channels and imported under GDP-compliant, cold-chain logistics to preserve product quality throughout transit.

Sourcing and Delivery of Vivitrol

NPP sources Vivitrol directly from authorized pharmaceutical distributors to ensure product authenticity and full traceability. Every shipment is handled under Good Distribution Practice (GDP) conditions from origin to the patient's doorstep.

Cold Chain and Handling

Vivitrol should be stored refrigerated at 2°C to 8°C; it may be stored at temperatures not exceeding 25°C for no more than 7 days prior to administration, and must not be frozen. NPP maintains a continuous, monitored cold chain throughout transit.

Delivery Timelines

Once documentation and regulatory approvals are in place, delivery timelines are communicated transparently at the time of quotation, accounting for import clearance and last-mile cold-chain logistics to the patient's city.

Availability of Vivitrol Across Major Cities in India

Patients across India can access Vivitrol through NPP's regulated import pathway, with addiction medicine specialists in major cities supporting the treatment process.

Mumbai

Leading hospitals in Mumbai support addiction medicine care coordination and documentation for Vivitrol access.

Delhi

Delhi's major hospitals assist patients with prescription support and documentation for Vivitrol.

Bangalore

Bangalore's specialist network offers access coordination for eligible patients seeking Vivitrol.

Chennai

Chennai-based addiction medicine specialists coordinate Vivitrol access alongside comprehensive recovery care.

Hyderabad

Hyderabad's care institutions support patients pursuing Vivitrol therapy.

Kolkata

Kolkata's specialist centers help coordinate documentation and treatment access for Vivitrol.

Pune

Pune-based specialists assist with prescription support and Vivitrol treatment planning.

Ahmedabad

Ahmedabad's specialty hospitals support the import and treatment process for Vivitrol.

Kochi

Kochi's specialist units assist patients with the documentation needed for Vivitrol access.

Chandigarh

Chandigarh's care centers support Vivitrol treatment coordination for patients from North India.

Jaipur

Jaipur's specialists help patients navigate the Vivitrol access process.

Lucknow

Lucknow-based centers assist patients pursuing Vivitrol therapy.

Bhubaneswar

Bhubaneswar's institutions support access to Vivitrol for eligible patients.

Guwahati

Guwahati's specialists help coordinate Vivitrol access for patients across the Northeast.

Patients in other cities across India can also access Vivitrol through NPP's nationwide coordination network.